Introduction: The usual treatment options for clinically localized prostate cancer carry a
significant risk of lasting side effects, including urinary, bowel, and sexual dysfunction, that …

We assessed the longitudinal alteration of the quality of life (QOL) of patients with localized
prostate cancer after radical prostatectomy or hormonoradiotherapy during 3-y follow-up. In …

Purpose: The goal of this study was to determine the relationship between primary
treatment, urinary dysfunction, sexual dysfunction, and general health-related quality of life …

OBJECTIVE To assess whether baseline health‐related quality of life (HRQOL) and
psychosocial profiles differ in patients with prostate cancer scheduled for radical …

Purpose: Men who undergo primary treatment for prostate cancer can expect changes in
health related quality of life. Long-term changes after treatment are not yet fully understood …

Objective: To determine the impact of salvage therapy for prostate‐specific antigen (PSA)
recurrence on the health‐related quality of life (HRQOL) of patients after radical retropubic …

OBJECTIVES: To validate an Italian version of the University of California-Los Angeles
Prostate Cancer Index (UCLA-PCI). METHODS: Men with prostate cancer treated with …

Background: Previous studies on the effects of different prostate cancer treatments on quality
of life, were confounded because patients were not comparable. This study examined …

Objectives. Treatment for prostate cancer has a significant impact on health-related quality of
life (HRQOL). We examined HRQOL immediately after diagnosis and treatment and 1 and 2 …

Background This study describes and compares health-related quality of life (HRQOL) of
prostate cancer patients who received either radical prostatectomy (nerve-sparing, nsRP, or …